Patents by Inventor Luciano Domenici

Luciano Domenici has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating chronic simple glaucoma with ophthalmic preparations based on BDNF (brain-derived neurotrophic factor)
    Patent number: 9387164
    Abstract: The present invention relates to ophthalmic preparations in the form of eyedrops based on BDNF (Brain-Derived Neurotrophic Factor). Said preparations can be administered topically to the intact eye surface, and are useful in the prevention and treatment of neurodegenerative disorders of the retina, optic nerve, lateral geniculate body and visual cortex, in order to prevent reduction of visual capacity and restore the normal visual function.
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: July 12, 2016
    Assignee: HMFRA HUNGARY LIMITED LIABILITY COMPANY
    Inventors: Luciano Domenici, Luca Giovannini, Marco Sanso′
  • OPHTHALMIC PREPARATIONS BASED ON PACAP (PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE) WHICH RESTORE THE NORMAL VISUAL FUNCTION IN EARLY GLAUCOMA
    Publication number: 20140315811
    Abstract: The present invention relates to ophthalmic preparations in the form of eyedrops based on PACAP (Pituitary Adenylate Cyclase Activating Polypeptide) which restore the normal visual function in retinal dystrophy/retinopathy and optic neuropathy, with special reference to glaucoma. Said preparations can be administered topically to the intact eye surface, and are useful in the treatment of various forms of retinal dystrophy/retinopathy and optic neuropathy, such as glaucoma.
    Type: Application
    Filed: April 5, 2012
    Publication date: October 23, 2014
    Applicant: HMFRA HUNGARY LIMITED LIABILITY COMPANY
    Inventors: Luciano Domenici, Marco Sanso', Luca Giovannini
  • OPHTHALMIC PREPARATIONS BASED ON BDNF (BRAIN-DERIVED NEUROTROPHIC FACTOR) AND THEIR USE
    Publication number: 20120258916
    Abstract: Said preparations can be administered topically to the intact eye surface, and are useful in the prevention and treatment of neurodegenerative disorders of the retina, optic nerve, lateral geniculate body and visual cortex, in order to prevent reduction of visual capacity and restore the normal visual function.
    Type: Application
    Filed: November 12, 2010
    Publication date: October 11, 2012
    Applicant: HMFRA HUNGARY LIMITED LIABILITY COMPANY
    Inventors: Luciano Domenici, Luca Giovannini, Marco Sanso'